Back to XERS

Rosalind Advisors, Inc. → XERS

Rosalind Advisors, Inc. XERS Position History

Xeris Biopharma Holdings, Inc. • Healthcare

Quarters held
4
Latest value
$24.7M
Q3 2026
Peak value
$24.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$16.6M
Q1 2026$18.7M
Q2 2026$23M
Q3 2026$24.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$24.7M2.58M——
Q2 2026$23M2.91M——
Q1 2026$18.7M3.23M——
Q4 2025$16.6M2.11M——

Other funds holding XERS

Other Rosalind Advisors, Inc. positions

DCTH

DELCATH SYSTEMS, INC.

$52.7M
DCTH

DELCATH SYSTEMS, INC.

$41.6M
FENC

FENNEC PHARMACEUTICALS INC

$34.3M
VSTM

VERASTEM INC

$34.1M
FENC

FENNEC PHARMACEUTICALS INC

$34M
DCTH

DELCATH SYSTEMS, INC.

$33M
DCTH

DELCATH SYSTEMS, INC.

$30.6M
SVRA

SAVARA INC

$20.5M